Combination of angiotensin converting enzyme inhibitor and...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/05 (2006.01) A61K 31/585 (2006.01) A61K 38/08 (2006.01) A61K 38/55 (2006.01)

Patent

CA 2212713

Combinations of an ACE inhibitor and an aldosterone receptor antagonist are described for use in treatment of circulatory disorders. Of particular interest are therapies using captopril or enalapril co-administered with a low- dose of spironolactone. This co-therapy would be particularly useful to treat or prevent the progression of congestive heart failure while avoiding or reducing aldosterone-antagonist-induced side effects such as hyperkalemia.

L'invention concerne des combinaisons d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un antagoniste du récepteur de l'aldostérone destinées à être utilisées dans le traitement de troubles circulatoires. Elle concerne surtout des thérapies dans lesquelles du captopril ou de l'énalapril sont co-administrés avec une faible dose de spironolactone. Cette thérapie combinée est particulièrement utile pour traiter ou prévenir la progression de l'insuffisance cardiaque congestive et supprimer ou réduire les effets secondaires induits par l'antagoniste de l'aldostérone, tels que l'hyperkaliémie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination of angiotensin converting enzyme inhibitor and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination of angiotensin converting enzyme inhibitor and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of angiotensin converting enzyme inhibitor and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1799304

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.